Medical University Of Graz — Sponsor Intelligence | 20 EU Trials

Filter these 20 trials by condition, phase, country and more.

Open in Search →

20 Registered trials

11 Recruiting

9 Completed trials

6 Countries active

24 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 3 Phase II: 4 Phase I/II: 1 Phase III/IV: 5 Phase IV: 6 Phase I (Other): 1

100%

9 of 9 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Type 1 diabetes mellitus 2 Acute myocardial infarction 1 Neonatal respiratory distress syndrome 1 Oxygen therapy 1 Hypertrophic cardiomyopathy 1 Cataract 1 Oxygen saturation 1 Vitrectomy 1 Age-related macular degeneration 1 Neovascular age-related macular degeneration 1

Top IMPs

AFLIBERCEPT 2 FARICIMAB 2 OXYGEN 2 VERAPAMIL HYDROCHLORIDE 2 AMOXICILLIN 1 BROMAZEPAM 1 COLECALCIFEROL 1 DABIGATRAN ETEXILATE 1 HYDROCHLOROTHIAZIDE 1 ICOSAPENT ETHYL 1 INSULIN ASPART 1 LUPULI FLOS DRY ALCOHOLIC EXTRACT, VALERIAN ROOT TE WITH ETHANOL/ETHANOL WATER, TROCKENEXTRAKT AUS PASSIONSBLUMENKRAUT 5-7:1, AUSZUGSMITTEL ETHANOL 60 % (V/V) 1

All trials

20 total

Two initial aflibercept 8 mg loading doses in treatment-naive neovascular AMD Recruiting

2025-523478-17-00 Phase IV 1 country AFLIBERCEPT
Changes in the wound microbiome and their impact on chronic wound healing under hyperbaric conditions Recruiting

2025-523863-39-00 Phase IV 1 country OXYGEN
Does the Length of Surfactant Treatment Affect How Well Very Premature Babies Stabilize? – Comparing 1-Minute and 5-Minute Methods Recruiting

2025-522754-39-00 Phase IV 1 country PORACTANT ALFA
HYDrochlorothiazidE compared to valsartan to treat arterial hypertension in patients with Hypertrophic obstructive CardioMyopathy – the HYDE… Recruiting

2024-520086-31-00 Phase IV 1 country HYDROCHLOROTHIAZIDE; VALSARTAN
The effect of music on perioperative anxiety and pain of patients undergoing retrobulbar anaesthesia Recruiting

2024-520132-15-00 Phase III/IV 1 country BROMAZEPAM; LUPULI FLOS DRY ALCOHOLIC EXTRACT, VALERIAN ROOT TE WITH ETHANOL/ETH…
Cangrelor in endovascular stroke treatment with emergent carotid artery stenting (CANCAS) Recruiting

2025-521564-35-00 Phase II 1 country
BIOmarker driven intensification of cardiovascular RISK factor management in patients with high risk for recurrent cardiovascular EVENTs The… Recruiting

2024-511950-35-00 Phase III 3 countries ICOSAPENT ETHYL
Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT) (REZAFECT) Recruiting

2024-519789-37-00 Phase III/IV 1 country REZAFUNGIN ACETATE
PostoperAtIve Oxygen suppLy to reduce tempOrary deSaturation in patients after non-cardiac surgery, a prospective, randomised controlled tri… Recruiting

2024-514285-39-00 Phase III 1 country OXYGEN
EFFECT OF ONCE VS TWICE DAILY ADMINISTRATION OF CORTICOSTEROIDS ON BLOOD GLUCOSE IN PATIENTS WITH ANCA-VASCULITIS MEASURED BY CONTINUOUS BLO… Recruiting

2024-516141-39-00 Phase III/IV 1 country PREDNISOLONE
Effect of high-dose vitamin D on 28-day mortality in adult critically ill patients with severe vitamin D deficiency Recruiting

2024-514556-32-00 Phase III 2 countries COLECALCIFEROL
An open-label extension multi-centre trial in adult subjects diagnosed with Type 1 diabetes mellitus exploring the effect of long-term Verap… Ended

2024-515234-33-00 Phase II 5 countries VERAPAMIL HYDROCHLORIDE; VERAPAMIL HYDROCHLORIDE PH. EUR.
The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with … Ended

2024-511366-36-00 Phase IV 1 country AMOXICILLIN
A single-center pilot study to establish a novel hypoglycemic clamp procedure to assess the time to spontaneous recovery from hypoglycemia i… Ended

2025-520996-16-00 Phase I/II 1 country INSULIN ASPART
A single center, open-label pilot study in healthy subjects using dermal open flow microperfusion to collect body fluids for bioanalytical m… Ended

2024-515780-62-00 Phase I (Other) 1 country
A randomised, double-blind, placebo controlled, parallel group, multi-centre trial in adult subjects with newly diagnosed type 1 diabetes me… Ended

2023-506545-27-01 Phase II 5 countries VERAPAMIL HYDROCHLORIDE
Two initial faricimab loading doses in treatment-naive neovascular AMD Ended

2024-514408-15-00 Phase IV 1 country FARICIMAB
Aflibercept 8mg for high-frequent Faricimab and prior Aflibercept 2mg treated Neovascular age-related macular degeneration: a monocenter, si… Ended

2024-515497-26-00 Phase III/IV 1 country
Vitamin-K-Antagonist and direct thrombin inhibitor Dabigatran for thrombus resolution in left ventricular thrombus after acute STEMI (ST-ele… Ended

2022-500383-35-00 Phase II 1 country DABIGATRAN ETEXILATE; PHENPROCOUMON
Faricimab for high-frequent Aflibercept treated Neovascular age-related macular degeneration: a monocenter, randomized, double-masked compar… Ended

2024-515377-10-00 Phase III/IV 1 country AFLIBERCEPT; FARICIMAB

Showing 1–20 of 20 trials

← All sponsors A–Z